AgraFlora Organics International Inc., a growth oriented and diversified international cannabis company, is pleased to announce its key asset, Propagation Services Canada (the “Delta Facility”) has completed additional steps in the process to obtain a license to cultivate cannabis from Health Canada and confirms its commitment to deliver the cultivation license at the Delta Facility prior to the end of Q2 2020, barring any material change in Health Canada’s service standards as a result of prevailing socioeconomic conditions.
On April 3rd 2020, the Delta Facility submitted responses to the third request for more information (the “RMI”) from Health Canada with respect to its cultivation application. The information submitted pursuant to the third RMI was submitted to clarify information previously submitted to Health Canada on February 28, 2020.
AgraFlora believes that the Company has taken the last major step towards licensing, having submitted robust responses to Health Canada’s requests in February and now again in March. Preparations have commenced to start cultivating once the license is obtained, including completing our genetics transaction to pursue our high-potency, low-cost product strategy.
Furthermore, AgraFlora would like to applaud Health Canada and its individual employees for maintaining licensing operations as we all navigate the challenges created by the COVID-19 crisis. While there is no guarantee as to the timing of the license grant, or if there will not be any further requests for additional information, based on available information the Company believes it has submitted all required information.
AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry. AgraFlora is focused primarily on the Canadian cannabis industry; the world’s most advanced and regulated legal cannabis market.
